Atlas Trials

A Clinical Study to Enable Process Validation of Commercial Grade OTL-101

Clinical trial NCT04140539 · WITHDRAWN

Trial details

NCT number
NCT04140539
Sponsor
University of California, Los Angeles
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Severe Combined Immunodeficiency Due to ADA Deficiency
Start date
2019-10-15
Primary completion
2021-08-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.